Jazz Pharmaceuticals (JAZZ) PT Lowered to $190 at B.Riley/FBR
Tweet
Share
E-mail
Get Alerts JAZZ Hot Sheet
Price: $234.88 -2.37%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
B.Riley/FBR analyst David Buck lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $190.00 (from $219.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- Fortescue (FMG:AU) (FSUGY) PT Lowered to AUD18 at RBC Capital
- Standard Chartered Plc. (2888:HK) (SCBFF) PT Raised to GBP248.40 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
David BuckSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
